Enterprise Value

86.98M

Cash

60.62M

Avg Qtr Burn

-7.856M

Short % of Float

19.98%

Insider Ownership

4.37%

Institutional Own.

25.12%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2

Data readout

PDS01ADC + ICI Details
Human papillomavirus

Phase 2

Data readout

PDS0101 + Chemo Details
Cancer, Cervical cancer

Phase 2

Data readout

PDS0101 + Keytruda Details
Cancer, Head and neck squamous cell carcinoma

Phase 2

Data readout

PDS0101 + Keytruda Details
Solid tumor/s, Cancer, HPV+ oropharyngeal cancer

Phase 2

Data readout

Phase 1/2

Data readout

PDS0301 + Docetaxel Details
Cancer, Prostate cancer

Phase 1/2

Data readout

Phase 1/2

Data readout

PDS01ADC Details
Kaposi Sarcoma

Phase 1/2

Data readout